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Trypanosoma evansi, the agent of “surra,” is a salivarian trypanosome, originating from Africa. It is thought to derive from
Trypanosoma brucei by deletion of the maxicircle kinetoplastic DNA (genetic material required for cyclical development in tsetse
flies). It is mostly mechanically transmitted by tabanids and stomoxes, initially to camels, in sub-Saharan area. The disease spread
fromNorth Africa towards the Middle East, Turkey, India, up to 53∘ North in Russia, across all South-East Asia, down to Indonesia
and the Philippines, and it was also introduced by the conquistadores into Latin America. It can affect a very large range of domestic
and wild hosts including camelids, equines, cattle, buffaloes, sheep, goats, pigs, dogs and other carnivores, deer, gazelles, and
elephants. It found a new large range of wild and domestic hosts in Latin America, including reservoirs (capybaras) and biological
vectors (vampire bats). Surra is amajor disease in camels, equines, and dogs, inwhich it can often be fatal in the absence of treatment,
and exhibits nonspecific clinical signs (anaemia, loss of weight, abortion, and death), which are variable from one host and one
place to another; however, its immunosuppressive effects interfering with intercurrent diseases or vaccination campaigns might be
its most significant and questionable aspect.
1. Introduction
Trypanosomes found in mammals (including humans) are
blood and sometimes tissue parasites of the order Kinetoplas-
tida, family of the Trypanosomatidae, genus Trypanosoma,
principally transmitted by biting insects, in which most of
them undergo a biological cycle. They are grouped into 2
sections: Stercoraria, which develops in the posterior part
of the insect digestive tract, including Trypanosoma cruzi,
both an extra- and intracellular parasite that is responsible
for Chagas disease, a major human disease affecting 15
million people and threatening 100 million people in Latin
America [1], and Salivaria which develops in the anterior
part of the insect digestive tract, such as the main African
livestock pathogenic trypanosomes, including the agents of
sleeping sickness, a major human disease affecting around
half a million people and threatening 60 million people in
Africa [2]. African livestock trypanosomes are threatening
48 million cattle in an area of 10 million sq/km in 37
African countries [3]; they cause fever, anaemia, weakness,
and nervous symptoms, responsible for major production
losses (meat, milk, draught power, fertility, and manure),
leading to cachexia and sometimes abortion and/or death
in the absence of treatment. Animal Trypanosomoses are
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nowadays a permanent constraint for livestock in Africa,
Asia, and Latin America, but their geographical distribution
is still evolving.
The main African pathogenic trypanosomes belong to
three subgenera of the salivarian section, namely, Nanno-
monas (Trypanosoma congolense), Duttonella (Trypanosoma
vivax), and Trypanozoon (Trypanosoma brucei group).These
parasites are mostly transmitted cyclically by the tsetse fly in
which the procyclic forms undergo a cycle of transformations
and multiplications leading to infective metacyclic forms,
which may be inoculated by the tsetse flies with its saliva
into a new host [4]. Due to this biological association, the
geographical distribution of African trypanosomes is closely
related to that of tsetse flies and then restricted to sub-Saharan
Africa, approximately below 15∘ North. However, in some
instances, in addition to the movements of their hosts, the
geographical distribution of trypanosomiasis does not fit that
of the tsetse fly, due to several other ways of transmission.
Amongst them, while direct vertical, oral, sexual, and iatro-
genic transmission may have an occasional impact, the most
important alternative way is mechanical transmission by
biting insects [5]. This way of transmission does not involve
a specific biological relation between parasite and vector.
In the absence of biological association and multiplication,
pathogens are simply sampled from one host, transported
to another, and inoculated with the saliva of the biting
insect, prior to the absorption of blood [6]. By this means of
transmission, some African pathogenic Trypanosoma species
could spread not only outside the tsetse belt inAfrica, but also
towards other continents [4].
In the subgenus Duttonella, T. vivax is mechanically
transmitted by tabanids and stomoxes, in both Africa [7, 8]
and Latin America [9–11], with an increasing impact in cattle
breeding. Trypanosoma vivax has not invaded Europe and
Asia, so far, but its potential for geographical distribution
is somewhat similar to that of T. evansi (in links with cos-
mopolitanmechanical vectors), though limited by a narrower
host range compared to T. evansi. Indeed, T. vivax infects
mainly bovines, and, to a lesser extent, horses [12, 13], so its
potential for geographical spread and enzootic establishment
would hardly compete with that of T. evansi.
In the subgenus Nannomonas, although T. congolense
was suspected early [14, 15], or proved to be mechanically
transmitted [16–19], the relatively low parasitaemia recorded
in its main host (cattle) does not favourmechanical transmis-
sion, which results in rare epidemiological evidence for such
transmission in the field [16, 20].
In the subgenus Trypanozoon, mechanical transmission
of T. brucei spp. was described both through contamination
by sucking flies and through serial biting action by biting
insects such as tabanids and stomoxes [21, 22], including
tsetse as mechanical vectors [23]. In the particular case of
Trypanosoma evansi, due to a loss of genetic material, the
parasite can no longer undergo its cycle in tsetse flies, thus
it is mainly mechanically transmitted by biting insects, which
probably selected parasites presenting the best ability for such
transmission. For this reason, T. evansi spread outside the
tsetse belt in Africa, towards the Middle East and Southern
Asia, and was exported with livestock to Latin America, and
even to Australia and Europe [4], although in the latter cases,
early eradication was possible.
It is not only the transmission of T. evansi that is different
from that of the other African trypanosomes, but also its
capacity to invade a host’s tissues (such as T. equiperdum).
The most pathogenic African livestock trypanosomes, T.
congolense and T. vivax, known as blood parasites, exhibit a
direct relation between pathogenic effects and the presence
of parasites in the blood. Although T. evansi can exhibit very
high parasitaemia, especially in camels, horses, and dogs (and
even occasionally cattle and buffaloes), it must be considered
as both a blood and tissue parasite, due to its ability to invade
the nervous system, not only in horses and and dogs but also
in cattle, buffaloes, and pigs [24].When the parasite is in very
low numbers (although able to induce immunosuppressive
effects), or when it is absent from the host blood stream
(although present in the nervous system), identification of
the etiological agent and evaluation of its pathogenic effects
and impact are especially difficult. For these reasons, medical
and economic impacts of T. evansi have most often been
underestimated. Amongst other things, this review aims to
provide a new view on this old parasite whose tendency to
travel does not appear to be extinct!
2. Origin, History, and
Geographical Distribution
Trypanosoma (Trypanozoon) evansi (Steel 1885) Balbiani,
1888, is the first pathogenic mammalian trypanosome to be
described in the world, in 1880, byGriffith Evans, in the blood
of Indian equines and dromedaries [4]. Its principal host is
originally the camel but it is present in dromedaries, horses,
and other Equidae as well as in a large range of other hosts.
Trypanosoma evansi is thought to be derived from T.
brucei brucei (cyclically transmitted by tsetse flies), but it is no
longer able to undergo its cycle in Glossina due to the loss of
the maxicircles of kinetoplastic mitochondrial DNA [25–27].
When this phenomenon occurred is not known, and some
authors even recently suggested that it might have occurred
in several instances [27].
In AfricaT. evansi is present in all countries where camels
are present, north of a line extending from Senegal (15∘
North) to Kenya (equator), above the tsetse belt; it is found
not only in Mauritania, Morocco, Algeria, Tunisia, Libya,
Egypt, Sudan, Eritrea, and Ethiopia, but also in the northern
parts of Mali, Burkina Faso, Niger, Nigeria, Chad, Somalia,
and Kenya [4]. Nowadays, its geographical distribution is
continuous from the northern part of Africa through the
Middle East to South-East Asia.
Although it is not possible to date the initial spread of T.
evansi eastwards, the analysis of historical data suggests that
surra was already present in India since time immemorial, at
least VIII centuries B.C., and that livestockmust have suffered
from it in the absence of treatment [4, 28]. It is present in
sub-Saharan and Mediterranean climates but can be found
in temperate areas as well as in arid deserts and semiarid
steppes.
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T. evansi is continuously present eastwards, in the Ara-
bian peninsula, including Saudi Arabia, Oman, the United
Arab Emirates, Jordan, Israel, Lebanon, Syria, Iraq, and
Turkey, and even with one occasional record in Bulgaria; it
is present from Iran to Kasakhstan as well as in Afghanistan
and Pakistan [16, 20, 29–31]. Curasson (1943), quoted by
Hoare [4], said that it is conceivable that surra was intro-
duced beyond Africa by the ancient Egyptians since they
used dromedaries in their military campaigns in Arabia,
Mesopotamia, Persia, and Baluchistan.
Trypanosoma evansi is present in India, China, Mongolia,
Russia (from Kuibyshev, 53∘N, to the Caucasus, 44∘N),
Bhutan, Nepal, Myanmar, Laos, Vietnam, Cambodia, Thai-
land, Malaysia, the Philippines, and Indonesia [32, 33]. Its
presence was suspected in Papua New Guinea but was not
confirmed [34]. It is so far absent from Australia [33].
The extension of T. evansi toward the West is more
recent. It was introduced into Latin America in the fifteenth
century with the Arabian horses belonging to the Spanish
conquistadores [35]. It was described for the first time on the
Island of Marajo (Amazon estuary) in 1827, and was further
observed in Paraguay (1847) in Pantanal, Brazil (1850), and
Mato Grosso, Brazil (1860), before spreading into Bolivia,
Venezuela, Guyana, and Colombia; it is present in Central
America up to Mexico [4]. Nowadays, epizootics due to T.
evansi are described periodically from Argentina to Panama
[36], a geographical distribution related to the vampire
bat Desmodus rotundus, a new host-vector reservoir of the
parasite [4].
Trypanosoma evansi recently arrived in the Canary
Islands (Spain) where it has been regularly observed since
1995 [37, 38]; it is thought to have been imported there by
illegal introduction of camels from enzootic countries such
as Mauritania or Morocco.
Toward the North, T. evansi was recently introduced on
the Spanish mainland, in the Province of Alicante, where an
outbreak occurred in a mixed camel and horse farm [39]. It
was also introduced into France, in 2006, in a single epizootic
focus in camels imported from the Canary Islands [40,
41]. These incursions into Europe should lead the sanitary
authorities to include T. evansi among the animal health
conditions for international trading of live animals within the
European Union and other countries; thus, new procedures
including diagnosis, curative or preventive treatment and
quarantine should be established to ensure the status of these
animals [42].
The geographical distribution of surra is represented in
Figure 1.
Historically, T. evansi could only be eradicated from areas
where it was detected very early and controlled. Indeed, when
introduced into America and Australia, in 1906 and 1907
[4], the infection was detected very early, during quarantine,
and the animals were killed. In all the other cases, once T.
evansi was established on an enzootic level, it was never
eradicated, most probably due to the existence of a wide
wild and domestic reservoir, the ability to be transmitted by
nonspecific mechanical vectors present all over the world,
and its ability to diffuse silently via healthy carriers. In such
conditions, a reduction of the infected areas is not expected;
Figure 1: Geographical distribution of Trypanosoma evansi in the
world (data synthesis).
on the contrary, the geographical spread of the parasite can
be predicted.
In fact, the evolution of the geographical distribution ofT.
evansi is related to the movements of infected animals. Inside
an infected country, the circulation of the parasite is almost
free, especially with healthy carriers such as bovines, and also
with more susceptible animals such as camels and mules,
carrying the parasite with mild or subclinical signs. From
one country to another, since the detection of the infection
is sometimes impossible, infected animals may occasionally
be allowed to enter uninfected areas, as was recently observed
in the Canary Islands, and the Spanish and Frenchmainlands
[42].
Consequently, T. evansi is an unapparent spreading para-
site.
3. Disease Synonyms and Parasite Taxonomy
Trypanosoma evansi belongs to the genus Trypanosoma,
subgenus Trypanozoon (salivarian section) together with
(i) T. brucei brucei, one of the agents of a disease called
Nagana in livestock, and for which wild animals often
act as a reservoir; Nagana is a complex of diseases due
to a number of Trypanosoma species includingmainly
T. brucei brucei,T. vivax, andT. congolensewhich have
a great impact on cattle breeding in Africa;
(ii) T. brucei rhodesiense and T. brucei gambiense are
responsible for Human African Trypanosomiasis
(HAT) or sleeping sickness, to which 60 million peo-
ple are exposed in 36 sub-Saharan African countries;
70,000 persons are thought to be infected [2, 43]
and the disease is most often fatal in the absence of
treatment;
(iii) Trypanosoma equiperdum, which is sexually transmit-
ted in Equidae and is responsible for a disease called
dourine.
Theword “surra” comes from the Indi andmeans “rotten,”
which qualifies the state of the animals after chronic evolution
of the disease [28]; this especially fits to the evolution of
the disease in camels. Trypanosoma evansi and surra are
found under various names; Hoare reviewed the literature
and found the parasite under more than 30 names [44], while
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the disease was found under an even greater number of ver-
nacular names. In Venezuela: T. equinum or T. venezuelense
was found to be the agents of Peste-Boba or Derrengadera
(which means “limping”), in relation to nervous clinical
signs in horses; in Argentina T. hippicum was found to be
responsible for Mal de Caderas, in relation to the posterior
paralysis of the legs, before the single name of T. evansi was
adopted; however the disease is still found under its local
names world over such asMurrina in Central America.
In Africa, for example, surra is found under the Arabic
nameDebab (El debab in Algeria) which means fly (linked to
the vector) [45], and alsoMbori in Sudan,Guifar orDioufar in
Chad,Menchaca (whichmeans “emaciated” despite sufficient
food provision) in Touareg populations of the Agadez area,
Niger [46], Yudleye or Yudle, which refers to an emaciated
camel aimlessly moving or jolting forward, or even Dukhan
or Salaf (or Salef ) in Somali [47] or Tahaga and su-auru
[44]. The parasite itself was found under various names: T.
soudanense, T. marocanum, T. aegyptum, and T. cameli before
the single taxon T. evansi was accepted [4].
In Asia the name surra is mostly employed, although sev-
eral other names were used before, such as purana (chronic
or old), tibarsa (three-year disease), and dubla (emaciated)
[32] or makhi ki bimari (horse-fly disease) [48]. However
the name T. evansi was widespread, while in some areas it
was found under other names such as T. annamense and T.
kirdanii [4].
It is generally admitted that T. evansi derives from T.
brucei through the complete loss of the maxicircles of kine-
toplastic mitochondrial DNA, which are required to undergo
the procyclic form in tsetse flies [27]. Losing in consequence
its ability to perform oxidative phosphorylation [49], T.
evansi is no longer able to undergo its cycle in Glossina [25–
27], and it is “trapped” in its blood stream form. T. evansi
also possesses only a single or very predominant minicircle
sequence class [50]. A complete loss of the kinetoplastic
DNA might even be possible and lead to akinetoplastic or
dyskinetoplastic T. evansi which are observed in field stocks,
but the use of some trypanocidal drugs may also enhance or
even induce the rate of dyskinetoplastic forms [49, 51].
T. equiperdum, a parasite of horses, is closely related to T.
evansi. It is sexually transmitted and responsible for a disease
called “dourine.” It is also thought to be derived fromT. brucei
by an alteration of the kinetoplastic DNA, but maxicircles
are still present in T. equiperdum, but with a single or very
predominant minicircle sequence class [50]. Distinction [52]
and even existence of this parasite are nowadays questioned
since genetic differentiation is almost impossible, especially
due to the absence of satisfying reference strains of T.
equiperdum [53], but the distinction is still clear when looking
at the minicircle complexity, which is very high in T. brucei
(hundreds of minicircle sequence classes) and scarce, if any,
inT. evansi andT. equiperdum.This diversity ismost probably
linked to sexual recombination, which can only occur in
Glossina [54]. In recent decades in Europe, dourine has not
been observed since 1994, though a recent outbreak occurred
in Italy in 2011 [55, 56]; this may be an opportunity to study
a recently isolated genetic material and provide some more
conclusive data.
Although a number of authors have attempted to genet-
ically characterize T. evansi and even to establish classifi-
cations [57–60], no convincing or useful classification has
ever emerged. Even its distinction from T. equiperdum is
sometimes questioned [52, 53]. The Trypanozoon subgenus
constitutes a homogeneous group [61] and, especially inside
T. evansi, most authors demonstrate a high molecular homo-
geneity [62], even though some reports state surprising
heterogeneity at strain level [63, 64].
In several instances it was suggested that T. evansi and
T. equiperdum should be renamed as T. brucei evansi and T.
brucei equiperdum [36]; this suggestion was recently renewed
based on the idea that these “subspecies” are petitemutants of
T. brucei by deletion of genetic material [27]. However these
technical considerations, which measure genetic divergence,
neglect the most important concern we may have for these
parasites: their pathogenicity, vectors, and host range and the
consequent geographical distribution. In that sense, it seems
reasonable and less confusing to keep the taxonomy as it is
by considering the particular parasitic niche of T. evansi [65]
in relation to its strong biological, ecological, and medical
differences from T. brucei. Indeed, other authors support the
hypothesis of a unique or at least a common genetic origin for
all T. evansi since they were able to identify a synapomorphic
gene in the parasite [61]. It is therefore advisable to keep the
current nomenclature of T. evansi, as suggested by Touratier
[66, 67], especially since the trinomial nomenclature is not
in accordance with the rules of the international code for
zoological nomenclature. Modification of this nomenclature
would be a confusing mixture of history, phylogeny, and
priority that a binomial nomenclature of life is supposed to
know and summarize.
It is fair to point out that the discovery of nuclear fission
never led to the terminology of the atom being abandoned,
although it is indeed fissile!
Some authors have suggested that the spread of T. evansi
and T. equiperdum was due to the lack of kinetoplastic DNA
[68], but so far, while the relation between inability to develop
in tsetse flies and akinetoplasty or dyskinetoplasty is clear,
the relation with the ability to be transmitted by mechan-
ical vectors, or to be sexually transmitted, has not been
confirmed. Losing kinetoplast does not transform T. brucei
into T. evansi (or T. equiperdum). Most probably, once T.
brucei had lost all, or part, of its kinetoplastic DNA, parasites
were selected either by mechanical vectors (selection of the
most prolific parasites in the blood of a given host due to
the very low quantity of blood transferred) or by direct
contamination (selection of the most invading parasites in
genital mucosae), in order to give birth to T. evansi and
T. equiperdum, as the best performers by mechanical and
direct sexual transmission, respectively. These speculations
have not yet had any genetic support and must therefore
be considered as pure hypothesis for further genetic charac-
terization. However, selection of predominant slender forms
of parasites by blood-sucking insects has been suggested
for a long time [69]. Clearly, since it was mathematically
demonstrated that the efficacy of mechanical transmission
is directly proportional to parasitaemia [70], biting insects
favour the spread of the most prolific strains of parasites in
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Figure 2: Hypothetical evolution tree for the Trypanozoon subgenus (data synthesis).
each host species. This consideration should be included in
the attempts to understand the derivation from T. brucei to T.
evansi in camels.
So far, it is advisable to keep the names of T. evansi and
surra for the parasite and the disease, which most probably
initially developed in camels.
Be that as it may, a hypothetical evolution tree can
summarize these data as presented in Figure 2.
Attempts to characterize T. evansi and T. equiperdum
stock using random priming have led to some polymorphism
being demonstrated among T. evansi strains, but so far it
has not been possible to distinguish it from T. equiperdum
[71, 72]. Other authors proposed RoTat 1.2 gene as a specific
gene whose presence would characterize T. evansi versus T.
equiperdum, but a number of studies have shown that this
gene can be absent from some T. evansi stocks [58, 73–76]. So
far, there is no single PCR test that can identify or distinguish
between T. evansi and T. equiperdum.
Lastly, although T. evansi could be considered as one of
the 5 subspecies of T. brucei, under the name of T. brucei
evansi, it seems justified to keep on using the species name
of T. evansi, unless a trinomial nomenclature is accepted. A
summary of the main characteristics of T. evansi is presented
in Box 1.
4. Morphological Features of T. evansi
When observed in fresh blood samples, T. evansi presents the
characteristics of slender Trypanozoon parasites: small size,
compared with Trypanosoma theileri, but large compared
to T. congolense, thin posterior extremity, free flagellum,
activemovements but producing limited displacements in the
microscope field, and highly visible undulating membrane
which “traps” the light (light may appear to be captured at
one end of the parasite and transferred to the other end to be
released).
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Trypanosoma evansi is sharing some characteristics with T. brucei brucei and more
generally with the subgenus Trypanozoon, such as the nucleic DNA [27], morphology and
morphometry of the blood stage parasite (especially slender forms: small subterminal
kinetoplast, thin posterior extremity, large undulating membrane, free flagellum, thin and
long parasite, central nucleus, etc.) [1], and ability for peroral and mechanical transmission
[9]. However, the effects of T. b. brucei have not been observed in some hosts due to their
absence from its geographical distribution, limited to the tsetse belt (e.g., the effect
of T. b. brucei on water buffalos is not known); thus, comparison is not always possible.
T. evansi and T. equiperdum are different from T. b. brucei since they suffer from a mutation
leading to the homogenization of their kinetoplastic minicircles, which make them unable
to properly edit their mitochondrial RNA; for this reason, they are unable to transform into
procyclic stage, thus to implement a cycle in tsetse flies; they are consequently locked into
the host as a blood stream form [27]; they are also unable to recombine their DNA since
this event occurs during the implementation of the cycle in the tsetse fly [54].
Distinct from T. equiperdum, T. evansi lost the kinetoplastic maxicircles, although the
extent of the loss is still under discussion since some part of the maxicircle DNA may be
remaining as shown in a Venezuelan strains [72].
Transformation into stumpy form, which is observed in T. brucei spp. when preparing to
the implementation of the cycle in the vector, became useless in T. evansi and T.
equiperdum, which most probably contribute to the rarefaction of the stumpy forms of
these parasites, thus predominantly found under the slender form (only very occasional
stumpy forms have been described [1]). In addition to this modification, the loss of
kinetoplastic DNA can be partial (dyskinetoplastic: Dk) or total (akinetoplastic: Ak).
Finally T. evansi is a parasite derived from T. brucei by deletion of mitochondrial DNA
(kinetoplastic DNA) leading to a strictly blood form parasite, morphologically monotonous,
dividing by binary fission in the blood of numerous hosts. Mechanical vectors most
probably selected the most prolific parasites in given hosts, leading to some divergence
among the strains; however this aspect will be discussed elsewhere, in a paper devoted
more extensively to the transmission of T. evansi. Additionally, distinction between T.
evansi and T. equiperdum would also be discussed based on the tropism of the latter for
genital apparatus, which trapped it in a given host, equines, due to a predominant sexual
transmission.
Box 1: The main characteristics of Trypanosoma evansi.
When observed on a Giemsa stained thin smear,T. evansi
has always been described as a monomorphic thin trypo-
mastigote parasite. By comparison with T. brucei, it shows
mostly slender forms (long free flagellum and thin posterior
extremity with subterminal small kinetoplast) (Figure 3) and
some intermediate forms (shorter free flagellum and poste-
rior extremity with almost terminal kinetoplast); however,
there are some scarce reports of stumpy forms in this
species, extensively studied by Hoare who concluded that
the polymorphism of T. evansi is an inconsistent feature
appearing sporadically [4].
The mean length of the parasite is 24 ± 4 𝜇m (min
15 𝜇m, max 33 𝜇m), without a sustainable relation between
geographical, host, or even strain origin. Similarly, the mor-
phological studies based on the absence of kinetoplast in a
variable proportion of the population ranging from 0% (T.
equinum) to 100% or intermediary (T. venezuelense) did not
lead to any substantial distinction, and the dyskinetoplastic
(or even akinetoplastic) strains are no longer regarded as
different from T. evansi. Lastly, past and recent observations
conclude that the size and shape of the blood forms of T.
evansi are not in relation with genetic characteristics, but
more or less with the growing conditions of the parasite and
the immune response of the host [77]. It must be emphasized
that in some instances truncated forms of the parasite are
observed (Figure 4), and they may be confusing for species
identification on blood smears, since the truncated parasite
may look alikeT. vivax as observed in the recent case in Spain
[39]; however, the kinetoplast is larger in T. vivax than in T.
evansi.
To conclude, T. evansi exhibits the slender morphology
and morphometry of the subgenus Trypanozoon, with very
limited polymorphism and without any characteristics qual-
ifying at species level.
5. The Large Host Range of T. evansi
Trypanosoma evansi has the widest host range amongst sali-
varian trypanosomes. It is especially pathogenic in camelids
and equids. T. evansi also has a huge range of domestic and
wild hosts worldwide. It has been hypothesized [26] that the
loss of maxicircle kinetoplast DNA was responsible for the
large range of hosts of T. evansi, but the same effects did
not lead to the same results in T. equiperdum since, for the
latter, the loss of maxicircle kinetoplast DNA [78] has led to
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Figure 3: Morphological features of Trypanosoma evansi: classical
forms in camel blood (M. Desquesnes). Legend: T. evansi in camel
blood (France), Giemsa stained blood smear; typical morphology
can be observed: large size (25–35𝜇m), small and subterminal
kinetoplast, thin posterior extremity, large undulating membrance,
central nucleus, and free flagellum.
a much narrower range of hosts. So it is still not understood
why T. evansi benefits from so large a range of hosts, unless
it is only a consequence of its geographical spread, which
suggests that T. brucei bruceiwould have the same large range
of hosts if it were able to spread outside the tsetse area. At least
experimentally, almost allmammals are receptive toT. evansi,
but only some of them are susceptible and may develop
significant clinical signs and play a role in its epidemiology,
as described below.
While almost all mammalian species are receptive, their
susceptibility not only is highly variable from one species to
another but may also be variable from one geographical area
to another. For this reasonwe based the description of its host
range on geographical units.
5.1. In Africa and the Middle East. Trypanosoma evansi is
mainly a parasite of camels (Camelus dromedarius), the host
species in which it probably early developed from T. brucei
brucei. However, it is pathogenic in other Camelidae, such
as the Bactrian camel (Camelus bactrianus). Trypanosoma
evansi is highly pathogenic in Equidae, especially in horses
(Equus caballus), and also in asses and donkeys (Equus
asinus) together with their crossbreeds (mules), in which it
is responsible for a sometimes acute disease, but most often
chronic.
Trypanosoma evansi can infect cattle (Bos taurus) in
Africa; however they are sometimes refractory to the infec-
tion [79]. Trypanosoma evansi can affect pigs (Sus scrofa),
domestic sheep (Ovis aries), and goats (Capra hircus). It is
considered as nonpathogenic in the African buffalo (Syncerus
caffer), in the serum of which a trypanolytic component
was recently demonstrated [80]. Trypanosoma evansi is occa-
sionally found in domestic cats (Felis domesticus) [81], and
regularly in dogs (Canis familiaris), whichmay act as sentinel
animals as observed in the surroundings of slaughter houses,
since they can acquire the infection when eating fresh raw
meat from infected animal. To conclude, in Africa, T. evansi
is mainly a parasite of camels, which act both as themain host
Figure 4: Morphological features of Trypanosoma evansi classical
and truncated forms (M. Desquesnes). Legend: T. evansi in cattle
blood (Thailand), Giemsa stained blood smear; typical morphology
can be observed: with thin posterior extremity (head of arrows),
together with truncated forms (arrows) whose posterior extremities
are truncated just below the kinetoplast location.
and a reservoir; it is sometimes found in horses and dogs, in
which the infection is most often fatal.
5.2. In Asia. T. evansi is a major parasite for water buffaloes
(Bubalus bubalis); in the Philippines it is considered as an
economically important disease which concerns not only
horses and buffaloes but also cattle, pigs, and goats [82].
In Asia, cattle are more receptive than in Africa or Latin
America, and they can exhibit strong clinical signs [83] and
very high parasitaemia (>108 parasites/mL) can occasionally
be observed in peripheral blood (unpublished observation).
Trypanosoma evansi has been found in elephants (Elephas
maximus indicus) in India where it affects them for work
[44]; it has also been found in sick elephants in Thai-
land [84] where some seropositive animals were detected
[83]. Trypanosoma evansi has been found in the antelope
(Saiga tatarica), the sambar deer (Cervus unicolor), Rusa
deer (C. timorensis) [85], hog deer (Axis porcinus) [86],
barking deer (Muntiacus muntjak), chital deer, or spotted
deer (Axis axis) [87] and in Capreolus spp. [44], as well
as in wild sheep (Ovis ammon), wild pigs, tapirs (Tapirus
indicus), rabbits, and pikas (Ochotona pallasi) and rodents
such as Rattus sp., R. tanezumi, Leopoldamys sp., Niviventer
fulvescens, Maxomys surifer and Bandicota sp. [88, 89] and
hamsters (Cricetus cricetus) [44]. Pikas and hamsters were
found to be spontaneously infected in enzootic areas in
Central Asia [4]. Mungos (Herpestes javanicus), the Indian
hare or “Black nap hare” (Lepus nigricollis), the orangutan
(Pongo pygmaeus), wolves, foxes (Vulpes sp.), jackals (Canis
aureus), woodcats (Felis bengalensis javanensis), civet cats
(Paradoxurus), badgers (Helictis pierri and H. personatus),
and hyenas can be naturally or experimentally infected,
and even chicks under experimental conditions [48, 90]. T.
evansi has been found in leopards (Panthera pardus), jaguars,
(Panthera onca), and tigers (Panthera tigris) in India [91–
93]. T. evansi was recently observed in Asian rhinoceros
(Dicerorhinus sumatrensis sumatrensis) in Malaysia [94] and
in the Himalayan black bear (Selenarctos thibetanus) [95].
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It has even been reported in chickens, but this single obser-
vation needs to be confirmed [96]; however the experimental
infection of chicks has been demonstrated for a long time [48]
and that of young pigeons more recently [97].
5.3. Surra in Australia and Europe. As it is able to infect deer,
wild pigs, and rodents [88], T. evansi can become established
in wild reservoirs all over the world, at the opportunity
of infected animal movements. Trypanosoma evansi was
introduced through infected horses in Australia and Canada
in the early XXth century, but control measures, including
slaughtering of infected animals, enabled early eradication
[4]. However, T. evansi is a huge threat for Australia since
it can affect horses, cattle, and camels (the latter, mostly
returned to the wild, would be especially difficult to control).
In addition to these traditional hosts, a possible role of
several wild animals from Australia was studied in order to
evaluate the risk of T. evansi dissemination from Papua New
Guinea; wild pigs and Rusa deer proved to be receptive but
of low susceptibility [34], while wallabies (Macropus agilis
and Thylogale brunii) proved to be highly susceptible and
exhibited acute clinical signs of surra, in most cases leading
to death within 8–61 days [98]. Similarly, the Japanese vole
(Microtus montebelli) proved to be highly susceptible since
all 16 animals experimentally infected died [99]. In all cases,
the potential for T. evansi to invade and establish as enzootic
disease in Australia, Japan, or even Europe is a true and real
threat. Trypanosoma evansi was introduced into the Canary
Islands, most probably from Mauritania or Mali, in camels,
and has yet to be eradicated [37, 100, 101]; from there it was
introduced into continental Spain and France [40, 41]. In
France it was controlled early and eradicated, but in Spain the
situation remains unclear since camels, and also horses, were
involved in the Alicante province [39, 102].
5.4. In the New World. T. evansi is found in host species
introduced by humans, such as horses, cattle, buffaloes, sheep,
and goats, but it has also been found in a very large range
of local wild hosts. It is principally pathogenic in horses,
sometimes with a very high prevalence, reaching 73% to 83%
in the outbreaks reported from Brazil or Guyana [9, 103, 104].
It is found in water buffaloes with a prevalence reaching 40%
in some instances [103, 105]; however, in the past, clinical
signs of trypanosomosis in buffalos have most often been
reported in infections due to T. vivax [106–110], rather than
T. evansi. It has been reported in cattle with a prevalence of
around 10% in Brazil, but there are no reports of pathogenic
effects. T. evansi is regularly found in dogs, which are also
infected by T. cruzi, and sometimes leishmania [111]; several
reports from Guyana mentioned ocular haemorrhages and
death with cardiac signs [9]. Guinea pigs (Cavia porcellus)
can harbour the parasite, specifically in Peru, where they are
raised for meat.
In addition to domestic hosts, T. evansi has been found in
a large range of wild hosts.
The Latin America vampire bat (Desmodus rotundus) is
simultaneously a host, reservoir, and vector of T. evansi; its
role in the epidemiology of T. evansi is therefore crucial since
it can not only transmit the disease but can act as a true
reservoir, keeping the parasite in the bat colony in the absence
of the main host [35].
Capybara (Hydrochoerus hydrochaeris), the biggest
rodent in the world, wild or raised under free-ranging or
semifree-ranging conditions, is potentially a major reservoir
[112, 113]; in a study in Brazil, capybaras proved to be of low
susceptibility and did not develop any anaemia [103]; in a
study in Venezuela, 25% to 70% of the animals were found
to be antibody carriers [114, 115]; a mathematical model to
study the dynamics of transmission and spread by capybaras
was recently developed [116].
Amongst camelids, Lama glama and Lama pacos are
sometimes found to be infected; under experimental con-
ditions Lama guanicoe proved to be fully receptive and
susceptible to infection [117].
Infections have been detected in South American coatis
(Nasua nasua), sometimes with a prevalence as high as
16% [103], wild dogs (Canis azarae), red howler monkeys
(Alouatta seniculus andA. ursina), white tail deer (Odocoileus
virginianus chiriquensis), brocket deer (Mazama satorii), wild
pigs (collared peccary, Tayassu tajacu, and white-lipped
peccary, Tayassu pecari), New World mouse (Oryzomys sp.),
ocelots (Leopardus pardalis) [9], and armadillos (Dasypus
sp.) as recently shown by PCR [118]. Marsupials such as the
omnivorous Didelphis sp., Monodelphis sp., and bats eating
fruits and arthropods such as Platyrrhinus sp., Carollia sp.,
and Myotis sp. have also been found to be infected [103];
however their epidemiological role is not known.
Lastly, in Latin America T. evansi has been found in
marsupials, Chiroptera, primates, lagomorphs, Edentates,
rodents, carnivores, perissodactyls, and artiodactyls; how-
ever, the epidemiological importance of each species has not
been determined and some may be epidemiological dead
ends for mechanical vectors, due to very low parasitaemia
rates [9, 36]. Nevertheless, these animals may still be a source
of infection for carnivores.
Finally, almost all mammals seem to be at least receptive,
if not susceptible to T. evansi, and even some birds may
be receptive; an exhaustive list of all potential hosts of T.
evansi can therefore hardly be established. To complete the
picture, a first, fully documented human case was recently
reported from India [119], in a farmer who had fluctuating
trypanosome parasitaemia associated with febrile episodes
for several months; in the absence of central nervous system
invasion, it was possible to treat the patient successfully with
suramin. Contamination by contact of a wound with infected
animal blood was suspected [120]. The potential of T. evansi
to infect humans will be reviewed and discussed elsewhere.
6. Clinical Signs
The pathogenic effects of T. evansi are classical such as any
other pathogenic mammal trypanosomes, including fever,
anaemia, loss of appetite and weight, loss of condition and
productivity, nervous signs and/or abortion, cachexia, and
death, with or without more peculiar signs related to the
host species [121]. However, what is quite surprising is the
variable intensity of these signs, from totally unapparent
to lethal, from one to another host species, but sometimes
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(a) Loss of weight and condition in a chronic evolution of surra
in a horse, Thailand
(b) Quick and fatal evolution of surra in a horse naturally
infected inThailand
Figure 5: Chronic (up) and acute (down) evolution of surra in horses (M. Desquesnes).
(a) Weight loss and testicular oedema (b) Detail of testicular oedema
Figure 6: Weight loss and testicular oedema in a horse infected with T. evansi in Thailand (M. Desquesnes).
within a host species, depending on the geographical area or
the epidemiological situation. Amongst nonvisible but very
important effects of surra is immunosuppression, which will
be presented in the next section.
Surra is basically a disease of camelids and equines, in
which typical clinical expression is described, but various
pathogenic effects are observed depending on the various
domestic and wild hosts concerned. These signs by host cat-
egories will be described in this section, while the variations
by geographical area and epidemiological situations will be
detailed in the epidemiology section.
6.1. Camels and Horses. The typical clinical expression of
surra can be described in camels and horses while donkeys,
asses, and mules are of lower susceptibility.
Surra in camels (Camelus dromedarius andC. bactrianus)
may be acutewith high fever, anaemia,weakness, anddeath; it
is also frequently fatal sometimes within a few months; how-
ever it ismore often chronic than in horses and can frequently
last 2-3 years (also called Tibersa) [122]. Signs of illness
appear with intermittent fever (41∘C), approximately about
a week; the animals appear dull and lustreless and become
progressively weaker with staring hair, loss of appetite and
weight, abortion, oedema (ventral parts, udder or scrotum,
and sheath), anaemia with pale mucous membrane, and
petechial or ecchymotic haemorrhages. All the age groups
can be infected but surra generally starts occurring shortly
after weaning. Nervous signs are sometimes observed, such
as periodic convulsions. The disease can last for several years
and it is thought that they will recover if they survive more
than 3 years. A specific odour of the urine is detected by camel
owners, which is efficient for diagnosing the disease [44].
In horses, the incubation period is 1–4 weeks, and
sometimes up to 8weeks, afterwhich the following symptoms
appear: fluctuating fever with high peaks with parasitaemia
(41.5∘C up to 44∘C), weakness, lethargy, anaemia, severe
weight loss (Figure 5(a)), transient local or general cutaneous
eruption, petechial haemorrhages on the eyelids, especially
the nictitating membrane (which may turn yellow when
reaching the icteric stage), vulvar and vaginal mucosa,
haemorrhages into the anterior chamber of the eye (where
trypanosomes can be also found in gelatinous material from
the inner canthus), abortion, and alteration of locomotion,
with nervous signs classically described in horses such as
“it may stumble at the fore legs and drag the hind legs”
[44], which probably called “Mal de Caderas”, and oedema
(submaxillary, legs, briskets, abdomen, testicle and sheath or
udder) appears after some time (Figure 6).
In chronic evolution staring hair and a progressive loss
of weight, which can lead to “living skeletons” as described
by Evans, despite quite a conserved appetite, can be seen,
but other authors mention a loss of appetite [104]; emacia-
tion is often accompanied by jaundice and highly coloured
urine [44]. Unless treated with trypanocidal drugs (dimi-
nazene aceturate, isometamidium chloride, quinapyramine,
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(a) Chronic evolution of surra in local cross-breed cattle,
Thailand (M. Desquesnes)
(b) Chronic evolution of surra in a buffalo which aborted twice,
Philippines (A. Dargantes)
Figure 7: Chronic evolution of surra in cattle and buffalo.
suramin, or cymelarsan), the disease can lead to death within
2–8weeks. Animals can either die suddenly andunexpectedly
or exhibit signs of delirium and struggle for hours before they
die of exhaustion (Figure 5(b)). T. evansi is present in both
intra- and extra-vascular fluids [123] which, together with
regular changes of its variable surface glycoprotein (VSG),
produce frequent relapses of parasitaemia and remittent
clinical signs. Intravascular coagulation is thought to be
responsible for persistent erection of the penis (Lingard 1893
quoted by [44]).
There are considerable differences in the severity of
syndromes caused by T. evansi depending on the virulence
of the strain and the susceptibility of the host, but acute signs
are often seen in naive populations with high mortality rates
above 50% [104]. On the other hand, in enzootic areas, horses
may exhibit a certain resistance with chronic or subclinical
cases and healthy carriers. Donkeys and mules exhibit the
same symptoms but milder than those in horses.
6.2. Cattle and Buffalo. Trypanosomosis due to T. evansi has
long been considered as a mild, chronic, or asymptomatic
disease in Bovinae (Bos, Bubalus, Syncerus, and Poephagus),
especially in Africa and Latin America, where it is sometimes
even difficult to infect animals experimentally [124]; simi-
larly, in Venezuela, although some clinical signs have been
recorded, the economic impact is not demonstrated [106].
The situation is quite different in India where the
pathogenic effects of surra were recorded as early as 1891,
with sometimes very high mortality rates (>90%), in reports
fully documented by Gill [48] from numerous areas of
India. Similarly, when surra was introduced in Mauritius the
mortality rate was very high.
Experimental and natural infection of cattle with an
Indonesian strain induced hyperthermia, haematocrit drops,
and loss of weight [125–127] and could also lead to death [87],
sometimes with nervous signs [128].
In Asia in the last 3 decades, numerous reports have
shown that surra is still, and maybe “again,” an important
disease in cattle and buffaloes, especially in Indonesia, the
Philippines, Thailand, and Vietnam [33]. Surra infection
results in anaemia, losses in weight, milk and meat pro-
duction, and losses in draught power, most often during
chronic evolution which can lead to totally wasted ani-
mals (Figure 7(a)); occasionally the evolution may be acute,
quickly leading to death. Indeed, fever, anaemia, abortion,
and reduction in body weight gain leading to the inter-
ruption in oestrous cyclicity have been recorded in heifers
in Indonesia [125]. In Thailand, the clinical signs recorded
in buffaloes are fever, stiffness, conjunctivitis, emaciation,
oedema (swelling of legs), inappetence, dyspnea, anaemia,
recumbency, diarrhoea, abortion, and death [85]. Nervous
signs are sometimes recorded with meningoencephalitis
[123]. Buffaloes imported from Australia were particularly
susceptible to the infection [129]. Similarly inNorthVietnam,
in the 1978–1981 period, hundreds of outbreaks led to 10%
death in buffaloes following massive imports of buffaloes
from Thailand and Cambodia; serological surveys showed
10–40% positive animals; similar studies in Thailand led to
15–54% seropositives in cattle and buffaloes [130].
In buffaloes, two syndromes have been described in the
Philippines: a wasting sickness lasting weeks or months and
terminating in recumbency and death and an acute disease
leading to death within hours [33, 131]; T. evansi was thought
to be responsible for the death of 10% of the buffaloes within
a few months. A very high rate of abortion (47%) was also
attributed to trypanosomosis (Figure 7(b)).
In dairy cattle, fever, abortion, and decreased milk pro-
duction are frequently reported [132, 133]; in beef cattle, when
surra occurs for the first time in a new area, highmortality can
be recorded [134].
In all cases, if the clinical signs recede, it is suspected that
surra exacerbates other latent infections [48], which will be
studied in the next section.
6.3. Sheep and Goats. Natural infection is generally con-
sidered as mild or asymptomatic in sheep [135]. In some
cases, experimental infections can even fail, but in others
they can lead to clinical signs, mainly fever (40∘C), lack of
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Figure 8: Hind leg paralysis in a pig naturally infected by
Trypanosoma evansi in Malaysia (courtesy, Dr. Chandrawathani
Panchadcharam).
appetite, and anaemia; during hyperthermia, modification
of behaviour such as exhaustion or sudden aggressiveness
has been observed; anaemia can recede after 2 months; par-
asitaemia is generally low (105 parasites/mL) and decreases
until undetectable for severalmonths; however, under certain
circumstances such as food restriction or transport stress,
parasites can relapse into the blood and clinical signs reappear
[136]. In experimental infection of Yankasa sheep with a
Nigerian isolate of T. evansi, acute and chronic evolutions
were observed, with fever, pale mucousmembrane, epiphora,
loss of appetite, emaciation, dullness, and rough haired
coat; in acute evolution the animals died within 2 weeks;
postmortem observation indicated enlargement of the spleen
and lymph nodes [137].
Goats are also most often of low susceptibility [69, 138];
thus in experimental infections with a camel isolate from
the Canary Islands they showed mild symptoms with a few
episodes of fever in early infection and arthritis in the next
6 months; although low, parasitaemia remained persistent
[139]. In the Philippines, experimental infection led to
the observation of fluctuating fever, progressive emaciation,
anaemia, coughing, testicular enlargement, and diarrhoea
but not in all animals [140]. However, other reports mention
moderate [141] but sometimes severe or fatal infections
with fever, lachrymation, salivation, loss of appetite, and
nervous symptoms (shivering and convulsion) followed by
hypothermia and death [142]. Ocular lesions have also been
recorded [143]. Finally, the susceptibility of goats seems to
be occasionally high in some reports, but, under natural
conditions, most of the reports mention mild clinical signs
due to T. evansi in goats [44, 144].
As sheep and goats are not regular hosts of T. evansi,
based on the reports available, it is difficult to decide on their
susceptibility.
6.4. Pigs. Infection in pigs has long been reported as very
mild or symptomless; however, symptoms such as fever,
anorexia, emaciation, and abortion were reported in an
outbreak in pigs in Malaysia [145], and there were reports
of low fertility in Thailand [146]. Even under experimental
conditions, clinical expression is mild or delayed for several
Figure 9: Fibrin deposit in the anterior chamber of the eye, in a
mixed German shepherd, naturally infected by Trypanosma evansi,
Chiang Mai, Thailand (courtesy Miss April Terry).
months. The immunosuppressive effects of the parasite have
been considered to be responsible for interference with the
efficacy of the vaccine against Classical Swine Fever [24].
Pig infection is often chronic with not only intermittent
fever, anaemia, loss of weight, abortion, and cutaneous rash,
but also late nervous evolution, with hind leg paralysis
(Figure 8). While most of the reports are mild cases, there
are a number of reports of severe outbreaks in Thailand; in
Chachoengsao province 85% of the animals were infected
[147] and relapsed after treatments with isometamidium
chloride; in Phitsanulok province, in 1984, on a sow and boar
farm, a severe outbreak was reported, with fever, anaemia,
urticarial plaques on ventral parts of the body, around teats
and udders or scrotum, lateral parts of the body and ears,
and even nervous symptoms of convulsion and circling [148];
in Nakhon-Pathom province, in 1982, 19/22 sows showed
clinical signs of surrawith fever (39–41∘C) and abortion [149].
In an experimental report cutaneous signs and abortion were
observed in sows [150]. It seems that, similarly to goats and
sheep, some rare outbreaks of surra may be severe in pigs,
but the reasons for these outbreaks are not known. Finally,
though little attention has been paid to surra in pigs, these
reports suggest that surramay have been underdiagnosed and
then underestimated in this species.
6.5. Carnivores. Dogs are highly susceptible to T. evansi,
and they often exhibit strong clinical signs leading to death,
sometimes within a week and most often within a month in
acute cases [48], especially in stray dogs which are not treated
[103] and also sometimes even despite treatments [151].
Clinical signs are intermittent fever (39∘C–41∘C), oedema of
the head, including larynx (to be differentiated from rabies),
oedema of the abdominal wall and legs, anaemia, weakness,
lack of appetite leading to emaciation and, sometime, paresis
of the hindquarters; myocarditis has been described and
can be fatal, as described in the first record of T. evansi
in French Guiana [9]; sexual excitement has also been
mentioned. Ocular signs are most often observed in dogs,
with conjunctivitis, lachrymation, keratitis, corneal opacity,
and/or haemorrhagic signs, which can lead to fibrin deposits
in the anterior chamber of the eye (Figure 9); parasites have
sometimes been observed in ocular aqueous fluid; these
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signs can recede after treatment in some instances [111, 136,
152–154]. Most of the cases are related to hunting dogs or
dogs living around slaughter houses, which suggests peroral
infection; however, seasonal effects have also been recorded
[151]. Transmission by stomoxes, which is the other name for
dog fly, is also possible providing the dog is living in close
contact with another infected animal.
Very little is known about natural infection in cats, but
T. evansi experimental infection in cats induced only mild
symptoms, such as fever, apathy, hyporexia, and vomiting
[155] as well as muscular pain, hyperproteinaemia, hyper-
globulinaemia, and hypoalbuminaemia [156].
Other carnivores have been found to be infected and
susceptible, such as ocelots (Felis pardalis), tigers [157],
hyenas, and leopards [158].
6.6. Other Naturally Infected Domesticated Species. In the
Asian elephant, severe symptoms are observed with fever,
anaemia, anorexia, oedema of the face, trunk, neck, brisket,
lower abdomen and limbs, dry and hard skin, sluggish
movement, dullness, restlessness, sleepy moods, reluctance
to work, ecchymoses, conjunctiva, and a high mortality rate
in Myanmar (Burma) and India [44]. In Thailand, fatal
[159] or moderate cases have both been described [84];
treatment with diminazen aceturate gives irregular results
with some failures using 5mg/Kg [159] and some successes
using 8mg/Kg [160], but in the latter case, elimination of the
parasite could not de demonstrated.
In deer, several reports gathered by Gill (1977) showed
variable signs depending on the host species; acute and
fatal evolutions were observed in Antilope cervicapra and
Axis sp. while it was more chronic in Axis axis and Rusa
timorensis, with anaemia, loss of weight, and abortion. Acute
signs were reported from outbreaks intoMauritius, in Cervus
unicolor, with acute fever, rapid loss of condition, emaciation,
anaemia, and death [48]. In SouthChina a 20%death rate was
recorded on a deer farm [161]. InThailand, inCervus porcinus
(hog deer), nervous signs were reported with paresis, lateral
recumbency, excitation, convulsion, and a high mortality
rate; presence of T. evansi in the Virchow-Robin spaces of the
brain was demonstrated by immunohistochemistry [86, 162].
Similarly, an outbreak in the Java deer (Cervus timorensis) was
reported from Malaysia (Perak) with anaemia, inappetence,
respiratory distress, recumbency, and lethal evolution; in this
case several other haemoparasites were present together with
T. evansi infection [163]; in total during this outbreak, surra
was responsible for a 27% mortalityrate [164].
6.7. Wild Hosts. Surra is classically described in a number
of favoured wild hosts such as vampire bats, capybaras, and
coatis; in the latter, experimental infections revealed the
existence of serious anaemia, myocarditis, and meningoen-
cephalitis [165]. Trypanosoma evansi is also present in a large
range of other wild animals including wild pigs, deer, and
rodents, which are mostly healthy carriers. However, more
susceptible host species have been identified recently.
Experimental infections have been carried out and have
demonstrated that a number of other species are receptive
and susceptible to the parasite. Amongst them, the wallaby,
which is the most common species of macropodid in south-
ern Papua New Guinea (PNG) and northern Australia, was
experimentally infected to test the potential for the spread
of surra in PNG and Australia where other potential hosts
are abundant, such as feral pigs and Rusa deer [34]. Agile
wallabies (Macropus agilis) and dusky pademelons (Thylogale
brunii) both proved to be very susceptible to the infection;
they developed high parasitaemia 6 days after infection,
persisting until death, between 1 week and 2 months; clinical
signs were anorexia, weakness, ataxia, and anaemia, while the
autopsies revealed pericarditis, splenomegaly and ulcerative
gastritis and enteritis [98].
Trypanosoma evansi was observed in 4 natural infections
in Himalayan charming bears, in Pakistan; the animals
exhibited pyrexia, accelerated pulse, tachypnea, depression,
anaemic mucous membranes, and ataxia [95].
Surra was suspected in 5 captive Sumatran rhinoceroses
(Dicerorhinus sumatrensis sumatrensis) in Malaysia present-
ing depression, anorexia, incoordination, muscle tremor,
nasal haemorrhage, recumbency, and labored breathing fol-
lowed by death. Trypanosoma evansi was found in 3 out of 5
animals, which all died [94].
Trypanosoma evansi was suspected in a herd of Ara-
bian dorcas gazelles (Gazella dorcas saudiya) and in one
Sand gazelle (Gazella subgutturosa marica) in Kuwait; the
main clinical signs were paresis of hindquarters and sudden
death; successful treatment was obtained with melarsomine
(http://priory.com/vet/Trypanosomagazelles.htm).
7. Immunosuppressive Effects
Trypanosomes survive and multiply in the extracellular
fluids of their mammalian hosts, especially in the blood.
They are thus confronted with both innate and adaptive
immune defences. Selective pressure has thus enabled them
to elaborate refined escape mechanisms. Besides its direct
pathogenicity, sometimes limited, but visible from clinical or
paraclinical observation, the impact of trypanosomiasis lies
in the ability of parasites to cause immunosuppression, which
is a dual biological phenomenon: on the one hand it prevents
immunopathology that can injure the host (synergism among
proinflammatory cytokines was demonstrated to contribute
to the development of anaemia [166]), but on the other hand,
it allows a small trypanosome population to evade the pro-
tective immune responses, remaining clinically silent in the
host further playing the role of a zoonotic or anthroponotic
reservoir. Immunosuppression also reduces the efficiency of
host immune responses, leading either to the development
of intercurrent diseases or depreciating the quality of vaccine
immunity. This immunopathological aspect was highlighted
in the early seventies [167] but seems to be speciesdependent
as demonstrated in murine experimental models, and T.
evansi seems to have developed particular strategies when
causing surra. The most well-known escape mechanism
developed by trypanosomes is the antigenic variation by
which they successively exhibit various main membrane
surface glycoproteins: the variant surface glycoprotein (VSG).
This can be considered as a first intention immunosuppres-
sion; however it proceeds from immunological exhaustion,
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since trypanosomes force their host to elicit successive direc-
tories of antibodies able to cope with emerging VSG variants,
while a new variant is planned to develop before the humoral
response is effective [168, 169]. Interestingly, a skin test in
rabbits infected by T. evansi demonstrated an immediate
type hypersensitivity reaction, followed by a delayed type
against the parasite surface-associated components, which
exhibited more intensity in cured animals than in infected
ones. This supports both VSG-specific antibody activity and
cellular immunosuppression [170]. Immunosuppression can
paradoxically be a consequence of an exacerbated inflam-
matory reaction initially developed to control parasitaemia,
as demonstrated by high levels of acute phase proteins (C-
reactive protein, haptoglobin, and alpha 2-macroglobulin)
concomitantly with immunoglobulins (Ig) M targeting VSG
[171]. Inhibition of blood acetylcholinesterase activity, an
inflammatorymarker in acute and chronicT. evansi infection
in rabbits, resulted in improved immunological response
against trypanosomes by proinflammatory cytokines [172,
173]. A consequence of inflammatory response is the increase
in extracellular adenine nucleotides such as ATP, which are
normally hydrolysed into AMP by ectoenzymes such as
NTPDase (EC 3.6.1.5, CD39).One of the immunosuppression
characteristics induced by T. evansi and linked to inflam-
mation was the altered NTPDase activity on the surface of
lymphocytes of infected rats [174].
The complement system is one of the first molecu-
lar defences in innate immunity, and antibody-dependent
complement-mediated lysis is probably one of the most
efficient early control strategies developed by the host.
Unfortunately, data from experimental infections in camels
indicated that, despite a slight initial increase, classical
complement pathway haemolytic activity dropped as the
infection progressed and correlated negatively with para-
sitaemia but was recovered following elimination of try-
panosomes, strongly suggesting an immunosuppression of
the molecular components of the immune system [175].
In terms of innate cell-mediated immune response against
trypanosomes, macrophages play a central role as antigen
presenting cells (APCs) and effector microbicidal cells. Try-
panosomes modulate macrophages through parasite factors
and host cytokines to control cell polarization into distinct
activation states (M1, M2), which may further contribute
to susceptibility or resistance to infection [176, 177]. Try-
panosome killing is assumed to occur via the induction
of classically activated macrophages (M1-type macrophages)
that produce high levels of inflammatory compounds such as
tumour necrosis factor 𝛼 (TNF-𝛼), reactive oxygen interme-
diates, nitric oxide synthase 2-dependent reactive nitrogen
intermediates, such as NO and associated molecules [177].
Interestingly, in murine models of T. evansi trypanosomosis,
whereas infection causes the induction of interferon 𝛾 (IFN-
𝛾), TNF-𝛼, and NO, none of these molecules was found to be
crucial for parasitaemia control and survival of the infected
animals [178]. A trypanosome-suppressive immunomodu-
lating factor (TSIF) was shown to induce TNF and NO
secretion by M1 macrophages, which concomitantly blocked
T cell proliferation in a NO- and IFN-𝛾-dependent manner.
Furthermore, TSIF had the capacity of downregulating type
2—oriented immune responses, being a key molecular actor
of the trypanosome-induced immunosuppression [179]. This
largely explains the elevated NO levels found in the serum of
rats infected by T. evansi, associated with a redox imbalance
(advanced oxidation protein products (AOPP) in serum and
superoxide dismutase (SOD) and catalase (CAT) activities
in blood) [180]. Moreover, this could be linked to one of
the main characteristics of trypanosome-induced immuno-
suppression in both experimental rodents and natural hosts,
which consist in the eliciting of suppressor macrophages that
results in a NO-mediated unresponsiveness in lymphocytes.
In that way, IFN-𝛾- and TNF-𝛼-dependent NO production
could be involved in the suppression of splenocyte prolifer-
ation occurring in T. evansi infection [178]. Amazingly, the
apparent loss of suppressor macrophage activity in cured
animals was shown to be due to NO-mediated apoptosis
of these cells [181]. Among APCs, dendritic cells (DCs) are
known to be strong elicitor and regulator cells of the immune
system. Behind the inflammatory cytokine and chemokine
storm caused mainly by macrophages in T. evansi infections,
increased expression levels for Ccl8 and Il10 in splenocytes
suggested an increase in the number and activity of regulatory
dendritic cells (DCs). The regulatory DCs became prevalent
during the progress of infection, therefore reducing the
amount of inflammatory DCs, and as a potential regulator
of the inflammatory responses, suggesting the use of the
inflammatory responses to immunosuppress the host, but
regulation to avoid irreversible pathophysiological effects
[182].
Despite the elements described above, and contrary to
tsetse fly-transmitted trypanosomes, the immunobiological
disorders occurring during a T. evansi infection have been
little documented, and the reports of immunological dys-
function occurring throughout the disease have only partially
addressed the corresponding control mechanisms. In water
buffaloes,T. evansi infection induced a significant decrease in
haemoglobin concentration, packed cell volume (PCV) and
red blood cell count, kidney function (creatinine and urea),
and liver alkaline phosphatase, whereas total the leucocytic
count, lymphocyte, and monocyte populations increased, as
well as liver functions (lactate dehydrogenase enzyme (LDH)
activity, globulin, total bilirubin, and indirect bilirubin),
showing a direct link between immune and metabolic disor-
ders [183–188]. In experimentally infected sheep, dissection
of the immune components involved in T. evansi-induced
immunosuppression highlighted that macrophages but not
CD8(+) T cells were mainly responsible for suppression
[189]. Actually, in terms of lymphocyte populations it was
shown that an increase in the CD4 : CD8 ratio and IgG1 was
associated with self-cure in T. evansi-infected sheep, whereas
a decrease in the CD4 : CD8 ratio and IgM associated with
an increase in the number of sIg+, CD45R+, CD1+, a major
histocompatibility complex (MHC) II+ circulating B cells,
was associated with infection and disease development [186,
190].
Recently, the relative contribution of IgG versus IgM
antibodies was detected for T. evansi infection in mice; the
absence of both B cells and IgM resulted in the abolishment
of first peak parasitaemia control and consequently rapid
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death of the infected deficient mice [178]. Passive transfer of
infection-induced IgG and IgM antibodies from normalmice
to B-cell- or IgM-deficient mice confirmed that antibody-
mediated T. evansi parasite control relied on IgM rather than
on IgG, in contrast to what happens in T. brucei and T. con-
golense infections [178]. However, while existing in the case
of T. evansi, it is not clear why IgM-mediated phagocytosis
would be more efficient and protective than IgG-mediated
phagocytosis of opsonised trypanosomes, which is classically
reported [191]. Contrary to T. brucei and T. congolense, T.
evansi exhibits distinct molecular and cellular dialogues and
conflicts when interacting with a mammalian host, since
despite an infection-associated induction of trypanocidal
inflammatory molecules, only IgM antibodies were proved
to significantly contribute to trypanosome control [177].
Moreover, to achieve immunosuppression of the host, even
if demonstrated only with T. brucei, it has been proven
that a nonrelated vaccine-induced protection was completely
abolished during an ongoing trypanosome infection. Initially,
this was attributed to active immunosuppression during
infection. However, even after antitrypanosome treatment
with Berenil, there was no recovery of vaccine efficacy against
an infectious challenge. These results suggest that at least
in a mouse model, trypanosomes are capable of perma-
nently destroying the host B-cell memory compartment,
in a nonantigen specific manner [192]. In the same way,
it has been proved recently that a T. evansi lymphotoxin
is able to induce CD45-dependent lymphocyte death [193],
which correlates with pioneering findings demonstrating that
membrane fractions of T. evansi elicit suppressor cells [194].
A disturbing consequence of the immunosuppression
induced by the trypanosome is the highest level of chemore-
sistance achieved using cloned trypanosomes in immuno-
suppressed mice. By frequent passage in immunosuppressed
mice given subcurative drug treatments, T. evansi was
demonstrated to rapidly develop high levels of resistance to
diminazene aceturate and isometamidium chloride, which
did not happen in immunocompetent mice. Immunosup-
pression of animals by a heavy parasite burden or stressful
conditions in conjunction with underdosing may there-
fore play an important role in the development of drug
resistance under field conditions [195, 196]. Moreover, the
quick degradation of the effectiveness of the host immune
system induced by T. evansi may explain the deadlock in
developing an efficient anti-trypanosome vaccine, despite
the identification of several nonvariant surface-exposed
trypanosome immunogens. More worrying is the loss of
effectiveness of conventional vaccines used in farm animals
demonstrated first in laboratory rodents, as illustrated for
Trichinella spiralis [189, 190]. Moreover, surra is suspected
to induce an immunosuppressive syndrome in cattle and
buffaloes, indicated by a lost capacity to mount humoral
and cell-mediated immune responses against heterologous
antigens, which would be responsible for failures of the vac-
cination campaigns against foot and mouth disease (FMD)
and haemorrhagic septicaemia (HS) [188, 197, 198]. It also
affects sheep by delaying and depressing the number of
lymphoblasts induced by Pasteurella haemolytica vaccine
administration [199] as well as pigs by interfering with their
immune response to Classical Swine Fever (CSF) vaccine
[24]. Some experiments have provided an explanation of the
cellular events linked to the loss of immunity, as significant
increases in circulating CD5+ B cells associated with signif-
icant decreases in CD5+, CD4+, and CD8+ T cell subsets
were observed in T. evansi-infected Pasteurella haemolytica-
vaccinated sheep at the inoculation site. Cell population
dysregulation was associated with suppression of local skin
reaction and serum IgG1 antibody responses to the vaccine
antigen [184].The same results were obtained when perform-
ing the experiment and analysis on lymphocyte phenotypes
draining froma lymphnode of aT. evansi-infectedPasteurella
haemolytica-vaccinated sheep, allowing the authors to con-
clude that these abnormal changes in the kinetics of efferent
lymphocyte phenotypes are likely to play a role in the genesis
of the generalized immunosuppression seen in trypanosome-
infected hosts [185]. Lastly, the proliferative responses of
T. evansi-infected Pasteurella haemolytica-vaccinated ovine
peripheral blood leucocytes (PBL) Concanavalin A (Con A),
bacterial lipopolysaccharide (LPS), PASTEURELLA antigen
(P.ag), or homologous trypanosome antigen (T.ag) were
significantly suppressed by the infection, but fully restored
by trypanocidal treatment for Con A, LPS and T.ag only,
whereas for P.ag the responsiveness of cells from uninfected
vaccinated sheep remained significantly higher than those of
cells from infected sheep [183].This strongly suggests that the
immunosuppression induced by T. evansi may have an even
more dramatic impact, because the treatment of trypanosome
infection would have no impact on the loss of protection
against common animal diseases.
Nevertheless, in the mouse model, some studies tend to
bring hope in the possibility of immunizing against T. evansi
since some authors succeeded in protecting animals from
trypanosome infections by immunisation against parasite
proteins such as 𝛽-tubulin [200, 201], actin [202], and VSG
[201–203]. Moreover, immunisation of mice with paraflag-
ellar rod proteins (PFR) 1 and 2 evidenced trypanolytic
properties of the anti-PFR1 and anti-PFR2 sera [204].
Immunosuppressive mechanisms occurring in T. evansi
infections have been partially characterized in a number
of models, from laboratory rodents to natural hosts, but
they need to be further investigated and understood and
would serve as a basis for studying infectious parasitic
immunosuppression.
8. Conclusion
In this paper, we have overviewed the basic characteristics
of T. evansi, including its origin, possibly multiple, which
suggests that it might be a plural parasite (petite mutant)
[27]. What happens exactly when T. brucei leaves Africa,
and is submitted to selection which may be governed by
venereal or mechanical transmission, is not fully understood
yet [68] and would require a complete review of its genetics
as well as those of T. equiperdum, a very close, if ever
different, parasite [53]. As the molecular epidemiology of T.
evansi is, in itself, a topic for a large review, it will be con-
ducted elsewhere. However, and lastly, losing some genetic
material (kinetoplastic maxicircles) made this parasite more
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efficient in terms of host and vector ranges. Indeed, when
leaving the tsetse belt “jail” in which it was trapped by
its cyclical development in tsetse flies, T. evansi developed,
or simply expressed, a surprising and spectacular ability to
develop in a very large range of hosts leading to a no less
spectacular, potentially unlimited, geographical distribution.
Although T. evansi has long been claimed to be a genetically
and morphologically highly homogeneous parasite [205],
recent investigations have demonstrated more diversity than
expected [206]. Moreover, it is obvious, when comparing
T. evansi to T. brucei, that some slight modifications in the
nucleotidic sequence of a genome have deeply impacted the
biological properties of a parasite, affording it very different
characteristics and behaviours, both in terms of host range,
pathogenicity, transmission, epidemiology, and geographical
distribution. Initially developing in camels inNorthAfrica,T.
evansi had—via biting insects acting as mechanical vectors—
iterative occasions to infect other mammal species living
in the vicinity of camels. When occurring, these occasional
infections might, or might not, lead to successful epidemio-
logical systems, depending on the characteristics of vectors,
hosts, environments, and animal management. This scenario
suggests that successful attempts may have led to the devel-
opment of “a number” of T. evansi due to selection through
the hosts and the vectors. Successful associations of host and
vectors of T. evansi resulted in a gradient of epidemiological
systems, from camels, in North Africa, to cattle and equids in
the Middle East, ending with water buffaloes in South-East
Asia. Due to its potentially unlimited host range, T. evansi
also possesses a capacity to invade new geographical areas,
as shown by the recent incursions made in into continental
Spain and France. Consequently, the scientific community
and sanitary authorities should pay attention to this parasite,
which may have opportunities for new developments in its
geographical distribution, towards the North, both in Europe
and America, or towards the South, in Australia.
Another important aspect of this parasite is the various
clinical or subclinical evolutions that may occur in several
hosts and/or areas. Camels, horses, and dogs remain the
most critical hosts for this parasite. In camels, classically,
the disease evolution can be acute, chronic, and subclinical,
including healthy carriers; the chronic infection leads to
name the disease as surra (rotten) Menchaca (emaciated) or
tibarsa (three years disease). In horses, T. evansi induces an
acute and most often fatal disease which temporary leads
to giving new specific names such as T. equinum or T.
hippicum before concluding on a single parasite exhibiting
pleomorphic signs in a large range of hosts. Trypanosoma
evansi can multiply with huge scores and then spread very
quickly, and in a very efficientmanner, through biting insects,
towards other surrounding host species; the role of biting
insects is pointed by local names such as El debab which
(flies) or makhi ki bimari (horse-fly disease) in Algeria and
Punjab, respectively. Moreover, in equids, weakness of the
legs or even nervous infections have led to naming the
disease Mal de Caderas or Derrengadera in South America.
Although it can most often kill horses and thus destroy its
own survival reservoir, these outbreaks are the opportunity
to spread to other reservoirs. In such mixed epidemiological
systems, the parasite can use equines to multiply and spread,
while it can use bovines (cattle and buffaloes) as mild regular
hosts and very efficient reservoirs. Other epidemiological
systems have developed in parallel, such as mules/horses
(tolerant reservoir host/acute outbreak substrate), or “peroral
infected flesh to carnivore system,” or “infected flesh to
wild rodents system” for which it is not yet understood
whether they are epidemiological dead ends or potentially
active reservoirs.Thepassage fromcarnivores or rodents back
towards herbivores is not clear enough and would need more
investigations to be clarified. Presumably the various degrees
of pathogenic effect observed in the various hosts affected
may reflect adaptations and/or selection of the parasites with
regards to the hosts or the means of transmission (biting
insects in herbivores or peroral infection in carnivores),
which may explain the various features offered by T. evansi
in different geographical or host specific situations.
The impact of the disease will be reviewed elsewhere, but
given the data reported on clinical and immunosuppressive
effects, it can be pointed out that the capacity of T. evansi to
spread undetected, to induce immune or vaccination failure
(thus impacting other disease developments or strategies
such as FMD,HS, or CSF), or to be hidden behind othermore
obvious diseases such as anaplasmosis or babesiosis clearly
suggests that it will also be necessary to pay more attention to
this understated parasite.
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